Record revenue masks margin recovery that isn't here yet

PG Electroplast crossed ₹2,000 crore in revenue for the first time, backed by genuine volume growth (Room AC +20-22%, Washing Machine +67%) and higher ASPs (+10-12% from commodity/currency pass-through). The operational execution is real. But margin compression—from 8.0% to 7.3% operating margin—reveals a troubling lag: input cost inflation outpaced pricing. Inventory markup ballooned from ₹700 Cr to ₹940 Cr for the same 5 lakh AC units, signalling that per-unit economics deteriorated despite management's on-call claims otherwise.

The first two held up cleanly: AC and Washing Machine posted highest-ever quarter sales, and volume/ASP splits are confirmed. The third is the pivot. Management says commodity costs were "partially passed" with full pass-through delayed to December. That delay is the entire story of Q1: copper at $14K/tonne (+78% from $7.8K), rupee at ₹95–96, resin prices elevated—none of this hit customer prices yet in full. Margin compression reflects this lag. The unproven claim is the fourth: that per-unit margin held steady. No quantitative proof was offered. The inventory markup suggests otherwise: either per-unit margin compressed, or working capital stress forced the company to carry more tonnage per rupee of revenue. The fifth claim—8% margins by full year—is now framed as an "aspiration" not guidance, and explicitly conditional on December pass-through. This is management retreating from prior calls' tone.

The stock rose +3.43% on day 1 post-result, but the pop faded: +1.03% by day 3, +0.86% by day 5. The fade is the market's own verdict: initial relief that revenue beat guidance gave way to skepticism about the margin story. At ₹601 (as of August 14), the stock is −6.73% from its all-time high but +37.67% off the 52-week low, suggesting modest drawdown but within normal range. Technical: RSI 59.6 (neutral), price above SMA50 and SMA200 (positive), but below SMA20 (a recent pullback).

Ownership flows are mixed. FII stakes declined from 13.02% (Q1 FY26) to 9.95% (Q1 FY27)—a 302 basis-point retreat—suggesting institutional investors are trimming conviction. DII roughly stable (18–24%), promoters holding steady near 43%. Bulk trading activity (Graviton Research Capital) shows market-neutral pairs trades (buy/sell same-day at ₹626.76/₹626.75), not directional conviction. No insider or promoter selling near the highs—that's a plus—but the FII fade paired with the post-result pop fading signals that large institutions are skeptical the margin recovery thesis holds up in December.

Not headline revenue growth (that's already proven). Track the organic operating margin trajectory from Q2 onwards. If Q2/Q3 margins are 7.4%+ and trending toward 8%, the December pass-through thesis holds and the stock's upside is real. If Q2 repeats Q1 at 7.3% or slides lower, expect the FII outflow to accelerate and the stock to re-rate lower as the margin recovery story fails. The margin is where management's credibility lives—revenue execution alone is not enough.